|

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

RECRUITINGSponsored by Aura Biosciences
Actively Recruiting
SponsorAura Biosciences
Started2025-11-12
Est. completion2028-08-15
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07421739

Summary

To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Have enrolled in the Aura-sponsored clinical trial AU-011-301.
* Access to a connected device (i.e., smartphone, laptop, or tablet)

Exclusion Criteria:

* None

Conditions5

CancerChoroidal MelanomaIndeterminate LesionsOcular MelanomaUveal Melanoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.